Skip Navigation


JAC Advance Access originally published online on April 5, 2007
Journal of Antimicrobial Chemotherapy 2007 59(6):1265-1270; doi:10.1093/jac/dkm036
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
59/6/1265    most recent
dkm036v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Szakonyi, G.
Right arrow Articles by Henderson, P. J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szakonyi, G.
Right arrow Articles by Henderson, P. J. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Special section: Efflux

A genomic strategy for cloning, expressing and purifying efflux proteins of the major facilitator superfamily

Gerda Szakonyi1, Dong Leng1, Pikyee Ma1, Kim E. Bettaney1, Massoud Saidijam1, Alison Ward1, Saeid Zibaei1, Alastair T. Gardiner2, Richard J. Cogdell2, Patrick Butaye3, Anne-Brit Kolsto4, John O'Reilly1, Ryan J. Hope1, Nicholas G. Rutherford1, Christopher J. Hoyle1 and Peter J. F. Henderson1,*

1 Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, Institute for Membrane and Systems Biology, University of Leeds, Leeds LS2 9JT, UK 2 Division of Biochemistry and Molecular Biology, Glasgow Biomedical Research Centre, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8TA, Scotland, UK 3 Department of Bacteriology and Immunology, Veterinary and Agrochemical Research Centre, VAR-CODA-CERVA, Groeselenberg 99, B-1180 Ukkel, Belgium 4 Department of Pharmaceutical Biosciences, University of Oslo, PO BOX 1068 Blindern, 0316 Oslo, Norway

Received 12 July 2006; returned 3 August 2006; revised 23 January 2007; accepted 26 January 2007

* Corresponding author. Tel: +44-113-343-3175; Fax: +44-113-1407; E-mail: p.j.f.henderson{at}leeds.ac.uk

A genomic strategy for the overexpression of bacterial multidrug and antibiotic resistance membrane efflux proteins in Escherichia coli is described. Expression is amplified so that the encoded proteins from a range of Gram-positive and Gram-negative bacteria comprise 5% to 35% of E. coli inner membrane protein. Depending upon their topology, proteins are produced with RGS(His)6-tag or a Strep-tag at the C terminus. These tags facilitate the purification of the overexpressed proteins in milligram quantities for structural studies. The strategy is illustrated for the bicyclomycin resistance efflux protein, Bcr, of E. coli.

Keywords: membrane transport proteins , antibiotic resistance , bicyclomycin , multidrugs , pathogens , Helicobacter pylori , Brucella spp. , Escherichia coli


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.